Literature DB >> 15155605

Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment.

Carol M Foster1, Pamela R Olton, Michael S Racine, David J Phillips, Vasantha Padmanabhan.   

Abstract

BACKGROUND: FSH concentrations are higher in girls than in boys before puberty. We hypothesized that steroid-mediated changes in FSH-regulatory proteins underlie the sex differences in FSH secretion and pubertal timing.
METHODS: FSH-regulatory proteins, LH, FSH and sex steroids were measured in five boys, 10 girls, and five girls with Turner syndrome before and during sex steroid treatment (girls, 0.05 mg/day estradiol; boys, 5 mg/day testosterone) for up to 4 weeks. Blood was obtained every 15 min from 20.00 to 08.00 h before and during sex steroid treatment.
RESULTS: The mean FSH concentration was higher in girls than in boys (P = 0.0044). Activin-A concentrations were greater (P < 0.0001) and inhibin-B concentrations lower (P < 0.0001) in girls compared with boys. Steroid treatment (i) suppressed LH/FSH concentrations in all subjects; (ii) increased the mean activin-A concentration in all but the Turner girls (P = 0.001); and (iii) decreased inhibin-B concentrations in boys (P = 0.005) but not in girls. Total follistatin and follistatin 288 concentrations did not differ by sex.
CONCLUSIONS: Sex steroids regulate circulating activin-A and inhibin-B concentrations in children. The lower inhibin-B and higher activin-A concentrations may explain the higher FSH and earlier onset of puberty in girls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155605     DOI: 10.1093/humrep/deh284

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Elpida C Skouvaklidou; Georgios Kynigopoulos; Zacharias G Saridakis; Aggeliki Apostolou; Georgios A Triantafyllou; Thomai Karagiozoglou-Lampoudi; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-08       Impact factor: 8.694

2.  The FSH-inhibin axis in prader-willi syndrome: heterogeneity of gonadal dysfunction.

Authors:  Varda Gross-Tsur; Harry J Hirsch; Fortu Benarroch; Talia Eldar-Geva
Journal:  Reprod Biol Endocrinol       Date:  2012-05-06       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.